Schroder Investment Management Group Grows Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Schroder Investment Management Group boosted its position in Molina Healthcare, Inc. (NYSE:MOH) by 89.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,355 shares of the company’s stock after buying an additional 7,266 shares during the quarter. Schroder Investment Management Group’s holdings in Molina Healthcare were worth $4,469,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MOH. Versant Capital Management Inc boosted its holdings in Molina Healthcare by 83.1% in the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after purchasing an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. purchased a new position in shares of Molina Healthcare during the 4th quarter valued at approximately $52,000. EverSource Wealth Advisors LLC boosted its stake in shares of Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $57,000 after buying an additional 88 shares during the last quarter. Harvest Fund Management Co. Ltd increased its stake in shares of Molina Healthcare by 895.0% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company’s stock worth $58,000 after buying an additional 179 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its holdings in Molina Healthcare by 337.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company’s stock valued at $58,000 after acquiring an additional 155 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company’s stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.10% of the company’s stock.

Molina Healthcare Price Performance

Shares of MOH opened at $347.26 on Friday. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $383.58. The stock’s fifty day moving average is $306.76 and its 200-day moving average is $308.73. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The firm has a market capitalization of $18.99 billion, a price-to-earnings ratio of 17.00, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. Equities analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Analyst Upgrades and Downgrades

MOH has been the topic of a number of research analyst reports. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Barclays decreased their price objective on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating for the company in a report on Friday, February 7th. Wells Fargo & Company upgraded shares of Molina Healthcare from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $295.00 to $372.00 in a research report on Wednesday, March 5th. Mizuho lowered their price objective on shares of Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Finally, StockNews.com cut shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Thursday. Seven analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Molina Healthcare has an average rating of “Moderate Buy” and an average target price of $348.75.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.